Pediatric low-grade glioma (pLGG) is the most common form of pediatric brain cancer. Day One’s OJEMDA™ is the first targeted treatment for pLGG tumors with BRAF fusions and mutations. Last week, on April 23, 2024, Day One Biopharmaceuticals was granted Accelerated […]
The urgent need for advanced childhood brain cancer research G34R-mutant pediatric diffuse glioma, a devastating brain cancer affecting children and young adults, poses significant challenges in treatment due to its aggressive nature, limited therapeutic options, and the long-term side effects.
This Pediatric Glioma has no known cure. Dr. Breunig is Taking on the Challenge. Read More »
Neuroblastoma is the most common extracranial solid tumor of childhood arising within the developing nervous system. Approximately half of neuroblastoma patients are diagnosed with high-risk disease, which is especially aggressive with a 50% survival rate. If a child’s high-risk neuroblastoma
Acute Myeloid leukemia (AML) is the second most common leukemia in children, and the prognosis after relapse is poor. Unlike current CAR T treatment for the most common childhood leukemia, acute lymphoblastic leukemia (ALL), patients with AML experience significant toxicity
Dr. Moghimi is developing next-generation CAR T-cells to treat pediatric AML. Read More »
As an infant, Lindsey Grubbs did what most babies do. She played, she napped, she cried, but she was dealing with something far from normal. “I was a baby, so of course I didn’t fully know what was happening
Clinical trial aims to bring new therapies to childhood brain tumors with low survival rates Bethesda, Md. – April 3, 2023 – CureSearch for Children’s Cancer, a national nonprofit on a mission to end childhood cancer by driving targeted and
CureSearch to fund Phase I clinical trial for pediatric brain cancer Read More »
“We were fortunate that CureSearch had just launched their Catapult Award program….It enabled researchers to access up to $2.5M in funding over three years, through a streamlined application process, rather than contending with multiple applications for smaller grants which would have lengthened
As we work to find new and less-toxic treatments for pediatric cancers, we know that smarter research funding is just one part of the solution. Long-term solutions require a seismic shift in the existing pediatric drug development process. This change
Updated 5/1/20 To the CureSearch Community: Like you, we’re closely monitoring the evolving situation surrounding COVID-19. With the safety of our patient families, volunteers and staff top of mind, all CureSearch-sponsored events through June 1st have been postponed, including our
COVID-19 Impact and Action Read More »
Mattel Children’s Foundation creates special doll to help children cope with hair loss Bethesda, MD – February 25, 2020 – Through a longstanding partnership with the Mattel Children’s Foundation, CureSearch for Children’s Cancer is proud to announce distribution of a new,
CureSearch to Distribute New Barbie Doll to Children Affected by Cancer Read More »
